ArticleAdvances in therapy2026
Estimating Long-Term Organ Damage Risk in Patients with Congenital Thrombotic Thrombocytopenic Purpura Receiving Recombinant ADAMTS13 Prophylaxis: A Structured Expert Elicitation Study.
Amie Padhiar et al.PubMed ↗Publisher ↗
No numbers read from the abstract.